Servier launches U.S. cancer business with plans to double headcount in next 5 years
May 09, 2019 at 17:00 PM EDT
France’s second-largest pharmaceutical company, Servier Group, opened its first U.S.-based commercial subsidiary in Boston this week, with plans to double the business over the next five years.